Rallybio Competitors and Similar CompaniesClear all
Rallybio's competitors and similar companies include Veloxis Pharmaceuticals.
 Rallybio Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins. |  Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | |
Founding Date | Founding Date 2018 | Founding Date 2002 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations New Haven, US HQ Farmington, US | Locations København, DK HQ Cary, US Cary, US |
Employees | Employees 28 | Employees 54 |
Financial | ||
Revenue (est.) | Revenue (est.) $858k (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) |
Net income | Net income ($9m) (FY, 2025) | Net income (kr5.3m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 182m | Total funding raised $ 60m |
For sources of this data, please see the company profile
View Company Profiles
Veloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company